Norway
· Delayed Price · Currency is NOK Elliptic Laboratories ASA Statistics
Total Valuation
Elliptic Laboratories ASA has a market cap or net worth of NOK 1.36 billion. The enterprise value is 1.28 billion.
| Market Cap | 1.36B |
| Enterprise Value | 1.28B |
Important Dates
The last earnings date was Wednesday, August 28, 2024.
| Earnings Date | Aug 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Elliptic Laboratories ASA has 105.27 million shares outstanding. The number of shares has increased by 8.16% in one year.
| Shares Outstanding | 105.27M |
| Shares Change (YoY) | +8.16% |
| Shares Change (QoQ) | -9.19% |
| Owned by Insiders (%) | 28.75% |
| Owned by Institutions (%) | 19.86% |
| Float | 70.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 75.88 |
| PS Ratio | 15.94 |
| PB Ratio | 4.28 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -51.43 |
| EV / Sales | 14.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -55.06 |
Financial Position
The company has a current ratio of 7.36, with a Debt / Equity ratio of 7.21.
| Current Ratio | 7.36 |
| Quick Ratio | 7.36 |
| Debt / Equity | 7.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.98 |
| Interest Coverage | -12.48 |
Financial Efficiency
Return on equity (ROE) is -7.81% and return on invested capital (ROIC) is -5.94%.
| Return on Equity (ROE) | -7.81% |
| Return on Assets (ROA) | -5.71% |
| Return on Capital (ROIC) | -5.94% |
| Revenue Per Employee | 1.03M |
| Profits Per Employee | -293,718 |
| Employee Count | 85 |
| Asset Turnover | 0.25 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.19% in the last 52 weeks. The beta is 0.74, so Elliptic Laboratories ASA's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -13.19% |
| 50-Day Moving Average | 11.58 |
| 200-Day Moving Average | 14.36 |
| Relative Strength Index (RSI) | 61.25 |
| Average Volume (20 Days) | 245,438 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Elliptic Laboratories ASA had revenue of NOK 87.21 million and -24.97 million in losses. Loss per share was -0.24.
| Revenue | 87.21M |
| Gross Profit | 6.19M |
| Operating Income | -31.90M |
| Pretax Income | -31.40M |
| Net Income | -24.97M |
| EBITDA | -31.14M |
| EBIT | -31.90M |
| Loss Per Share | -0.24 |
Balance Sheet
The company has 96.90 million in cash and 22.90 million in debt, giving a net cash position of 73.99 million or 0.70 per share.
| Cash & Cash Equivalents | 96.90M |
| Total Debt | 22.90M |
| Net Cash | 73.99M |
| Net Cash Per Share | 0.70 |
| Equity (Book Value) | 317.52M |
| Book Value Per Share | 3.02 |
| Working Capital | 163.60M |
Cash Flow
In the last 12 months, operating cash flow was -23.25 million and capital expenditures -71,000, giving a free cash flow of -23.32 million.
| Operating Cash Flow | -23.25M |
| Capital Expenditures | -71,000 |
| Free Cash Flow | -23.32M |
| FCF Per Share | -0.22 |
Margins
Gross margin is 7.10%, with operating and profit margins of -36.58% and -28.63%.
| Gross Margin | 7.10% |
| Operating Margin | -36.58% |
| Pretax Margin | -36.00% |
| Profit Margin | -28.63% |
| EBITDA Margin | -35.70% |
| EBIT Margin | -36.58% |
| FCF Margin | -26.74% |
Dividends & Yields
Elliptic Laboratories ASA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.16% |
| Shareholder Yield | -8.16% |
| Earnings Yield | -1.83% |
| FCF Yield | -1.72% |
Stock Splits
The last stock split was on September 30, 2021. It was a forward split with a ratio of 10.
| Last Split Date | Sep 30, 2021 |
| Split Type | Forward |
| Split Ratio | 10 |